About
Research
Patient Care
Education
Community
May 03, 2024
Joe C. Wen & Family Center for Advanced Care Center opens its doors
The first part of the construction of UCI Health ― Irvine is complete with the opening of the Joe C. Wen & Family Center for Advanced Care on May 1.The second phase of the $1.3 billion Irvine medical complex, the Chao Family Comprehensive Cancer Center and Ambulatory Care building, will open to patients in July.
Dr. Alexandre Chan Recognized with Helen McKinnon Award from International Society of Oncology Pharmacy Practitioners (ISOPP)
The Helen McKinnon Award, named after a founding member of ISOPP, recognizes people who have significantly contributed to the group and the profession of oncology pharmacy at large.
May 1, 2024
May 01, 2024
April 17, 2024
Apr 10, 2024
Dr. Alexandre Chan Given Basic and Clinical Research Literature Award from Hematology/Oncology Pharmacy Association (HOPA)
Dr. Alexandre Chan, Founding Chair of the Department of Clinical Pharmacy Practice in the UC Irvine School of Pharmacy & Pharmaceutical Sciences, has been selected by the Hematology/Oncology Pharmacy Association (HOPA) as the recipient of their Basic and Clinical Research Literature Award!
Apr 08, 2024
Dr. Shawn Griffin Received Volunteer Award from Hematology/Oncology Pharmacy Association (HOPA)
Dr. Shawn Griffin, health sciences assistant clinical professor in the UC Irvine School of Pharmacy & Pharmaceutical Sciences, was honored by the Hematology/Oncology Pharmacy Association (HOPA) with their Volunteer Award!
Apr 05, 2024
UC Irvine-led research team builds first tandem repeat expansions genetic reference maps
A research team led by the University of California, Irvine has built the first genetic reference maps for short lengths of DNA repeated multiple times which are known to cause more than 50 lethal human diseases, including amyotrophic lateral sclerosis, Huntington’s disease and multiple cancers.
April 3, 2024
Events, Announcements, Funding Opportunities and More
April 03, 2024
March 20, 2024
Mar 18, 2024
UC Irvine-led research team discovers role of key enzymes that drive cancer mutations
A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for intervention strategies.